Results 81 to 90 of about 8,517,970 (127)

Safety evaluation of certain contaminants in food: prepared by the ninetieth meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA)

, 2023
v, 394 p.This volume presents safety evaluations of selected food contaminants reviewed by the Joint FAO/WHO Expert Committee on Food Additives (JECFA) at its ninetieth meeting, held online in November 2020.
World Health Organization, Food and Agriculture Organization of the United Nations   +1 more
core  

Safety evaluation of certain contaminants in food: prepared by the ninety-first meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA)

, 2023
v, 352 p.This volume presents safety evaluations of selected food contaminants reviewed by the Joint FAO/WHO Expert Committee on Food Additives (JECFA) at its ninety-first meeting, held online in November 2020.
World Health Organization, Food and Agriculture Organization of the United Nation   +1 more
core  

Global pharmacovigilance analysis of antimicrobials used in periodontal therapy: safety profiles of minocycline, doxycycline, and chlorhexidine

Head & Face Medicine
Background Minocycline, doxycycline, and chlorhexidine are widely used as adjuncts to non-surgical periodontal therapy. Although their efficacy has been demonstrated in clinical trials, comparative real-world safety data across diverse populations remain
Wanchen Ning, Xiangyu Huang, Simin Li, Linxin Jiang, Daniel R. Reissmann, Deborah Kreher, Gerhard Schmalz, Hongxing Chu, Shaohong Huang   +8 more
doaj   +1 more source

Adverse drug reaction profiles of histone deacetylase inhibitors

Scientific Reports
The safety and tolerability of histone deacetylase inhibitors (HDACIs) were always a matter of concern. This study aimed to explore the global observational adverse drug reaction (ADR) profiles of the HDACIs: vorinostat, belinostat, panobinostat ...
Ruqayyah Begum, Jason L. Parsons, Alan M. Jones   +2 more
doaj   +1 more source

Immune-related adverse-event signals of durvalumab: cross-database pharmacovigilance analysis of WHO-VigiAccess and FAERS with comparative assessment versus atezolizumab

Abstract Background: Durvalumab has become a key programmed death-ligand 1 (PDL1) inhibitor in modern oncology, particularly in thoracic malignancies. As its clinical use expands, immune-related adverse events (irAEs) have emerged as a major safety concern.
Furong Sun, Qinwei Wu, Jing Li, Shouzhen Liu, Jie Hua, Yuzhu Gao   +5 more
openaire   +1 more source

WHO consolidated guidelines on tuberculosis Module 1: prevention - tuberculosis preventive treatment, second edition [PDF]

268 p.The 2024 recommendations for the programmatic management of TPT are released as part of Module 1 of the WHO consolidated TB guidelines series. The guidelines are complemented by an operational handbook, that provides practical advice on how to ...
WHO
core  

Using WHO Mortality Data For International Comparison [PDF]

, 2002
The World Health Organization provides detailed mortality data files through the WHO Mortality Database (WHO MDB). While valuable information is available from the WHO MDB, there are some inherent difficulties in the utilisation of such data for the user.
Oldenburg, Brian F., Walker, Sue M., Tong, Shilu, McKenzie, Kirsten, Stahl, Caroline   +4 more
core   +1 more source

WHO Expanded Programme of Research, Development, and Research Training in Human Reproduction : summary status report

, 1973
Progress report on implementation of a WHO research training centre programme on the control of human fertility - (1) reports on the status of clinical research centres, task forces on contraceptives and other methods of fertility control, programme ...
WHO
core   +1 more source

The development of community health care in Shanghai : emerging patterns of primary health care for the ageing population of a megalopolis

, 2004
WHO/WKC/Tech.Ser./04.161 ...
WHO Centre for Health Development (Kobe, Japan)
core  

Global review on oral health in ageing societies

, 2002
WHO/WKC/Tech.Ser./02.280 ...
WHO Centre for Health Development (Kobe, Japan)
core